Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Optimizing Antimicrobial Stewardship (AMS) Interventions and Outcomes in Clinical Outcomes, Optimal Use and Resource UtilizatioRelease Date:Research Inflammation & Immunology China Optimizing Disease Management to Improve Alopecia Areata Quality of CareRelease Date:Quality Improvement Inflammation & Immunology China Research on Exploring Disease Assessment and Prioritizing Systematic Treatment for VitiligoRelease Date:Research Inflammation & Immunology China Quality Improvement in Molecular Testing Pathways for Metastatic Colorectal Cancer (mCRC)Release Date:Partner: American Society for Clinical Pathology (ASCP)Quality Improvement Oncology USA Personalized monitoring&treatment for HR+, HER2- mBC patients treated w CDK4/6i: incorporating Patient complexity risk factorsRelease Date:Quality Improvement, Research Oncology Italy Providing Appropriate Medical Care for IBD PatientsRelease Date:Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)Quality Improvement Inflammation & Immunology Japan Administration of brentuximab vedotin alone or in combination with other approved agents in pre and/or peri CAR-TRelease Date:Research Oncology USA Fostering Educational Initiatives for ALK+ Metastatic Non-Small Cell Lung Cancer(mNSCLC) Tyrosine Kinase Inhibitors(TKI) TherapyRelease Date:Education Oncology Canada Title Grant Type Focus Area Country Application Due Date Promotion of the Appropriate Diagnosis and Treatment of Pediatric Neurogenic BladderRelease Date:Education Internal Medicine Japan Closing Knowledge Gaps in Transthyretin Cardiomyopathy (ATTR-CM)Emerging Markets (Asia, Latin America, Africa, and Middle East)Release Date:Education Rare Disease All Developing Clinical Research and Publication Skills（Asia, AfME, Latin America and China）Release Date:Partner: British Medical Journal (BMJ)Education Internal Medicine All A Phased Approach to Understanding and Addressing Healthcare Disparities for People of ColorRelease Date:Partner: Conquer Cancer, The ASCO FoundationResearch Oncology USA PCF-Pfizer-Myovant Relugolix Challenge AwardsRelease Date:Partner: The Prostate Cancer Foundation and Myovant Sciences GmbHResearch Oncology USA BRAF-mutation Biomarker Testing in Colorectal Cancer and MelanomaRelease Date:Quality Improvement Oncology Canada Pfizer Innovation Challenge: Patient Preference Database BlueprintRelease Date:Research Support for the Professions All Management of Uterine Fibroids and EndometriosisEducation Internal Medicine USA COVID-19 Impact and SARS-CoV-2 Viral LifecycleRelease Date:Education Hospital USA Addressing Knowledge Gaps on Biosimilar Use in Inflammatory ConditionsRelease Date:Education Inflammation & Immunology USA Dermatology Research Fellowship in Skin of ColorFellowship Inflammation & Immunology USA NSCLC Therapy Management for Optimal Outcomes(Asia, Africa, Middle East, Latin America)Release Date:Quality Improvement Oncology All